NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $19,433,000 | +51.9% | 578,377 | +48.6% | 0.01% | +40.0% |
| Q4 2018 | $12,796,000 | -75.6% | 389,295 | -54.7% | 0.01% | -41.2% |
| Q3 2018 | $52,406,000 | +157.5% | 859,674 | +106.3% | 0.02% | +21.4% |
| Q2 2018 | $20,353,000 | -70.3% | 416,810 | -35.3% | 0.01% | -69.6% |
| Q1 2018 | $68,474,000 | +83.3% | 644,401 | +3.0% | 0.05% | +84.0% |
| Q4 2017 | $37,355,000 | +180.9% | 625,499 | +12.9% | 0.02% | +177.8% |
| Q3 2017 | $13,296,000 | +18.3% | 553,989 | -3.7% | 0.01% | +12.5% |
| Q2 2017 | $11,243,000 | -34.8% | 575,108 | -21.8% | 0.01% | -33.3% |
| Q1 2017 | $17,253,000 | +134.2% | 735,117 | +22.4% | 0.01% | +140.0% |
| Q4 2016 | $7,366,000 | -23.7% | 600,363 | +6.8% | 0.01% | -16.7% |
| Q3 2016 | $9,655,000 | +18.8% | 561,999 | -1.6% | 0.01% | 0.0% |
| Q2 2016 | $8,124,000 | -0.2% | 570,890 | -3.5% | 0.01% | 0.0% |
| Q1 2016 | $8,138,000 | -19.6% | 591,820 | -1.5% | 0.01% | -25.0% |
| Q4 2015 | $10,124,000 | +51.4% | 600,840 | -1.5% | 0.01% | +60.0% |
| Q3 2015 | $6,687,000 | -15.3% | 610,156 | -3.3% | 0.01% | -16.7% |
| Q2 2015 | $7,894,000 | -0.9% | 631,041 | -12.9% | 0.01% | 0.0% |
| Q1 2015 | $7,965,000 | -29.5% | 724,126 | -0.6% | 0.01% | -25.0% |
| Q4 2014 | $11,296,000 | +24.2% | 728,756 | -3.3% | 0.01% | +33.3% |
| Q3 2014 | $9,092,000 | -7.5% | 753,273 | -1.7% | 0.01% | -14.3% |
| Q2 2014 | $9,827,000 | +9.1% | 766,539 | +3.2% | 0.01% | +16.7% |
| Q1 2014 | $9,004,000 | +9.0% | 742,913 | +2.1% | 0.01% | 0.0% |
| Q4 2013 | $8,262,000 | +8.1% | 727,966 | -0.5% | 0.01% | 0.0% |
| Q3 2013 | $7,643,000 | -10.7% | 731,394 | -1.3% | 0.01% | -14.3% |
| Q2 2013 | $8,560,000 | – | 741,164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |